These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 32193875)

  • 1. Electropharmacological Characterization of Aciclovir in the Halothane-Anesthetized Dogs: A Proposal of Evaluation Method for Cardiovascular Safety Pharmacology of Anti-virus Drugs.
    Kondo Y; Hagiwara-Nagasawa M; Kambayashi R; Goto A; Chiba K; Nunoi Y; Izumi-Nakaseko H; Matsumoto A; Sugiyama A
    Cardiovasc Toxicol; 2020 Aug; 20(4):419-426. PubMed ID: 32193875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electropharmacological effects of amantadine on cardiovascular system assessed with J-Tpeak and Tpeak-Tend analysis in the halothane-anesthetized beagle dogs.
    Cao X; Nakamura Y; Wada T; Izumi-Nakaseko H; Ando K; Sugiyama A
    J Toxicol Sci; 2016; 41(3):439-47. PubMed ID: 27193735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo characterization of anti-atrial fibrillatory potential and pharmacological safety profile of I
    Nunoi Y; Kambayashi R; Goto A; Hagiwara-Nagasawa M; Chiba K; Izumi-Nakaseko H; Kawai S; Takei Y; Matsumoto A; Watanabe Y; Sugiyama A
    Heart Vessels; 2021 Jul; 36(7):1088-1097. PubMed ID: 33763729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental analysis of the onset mechanism of TdP reported in an LQT3 patient during pharmacological treatment with serotonin-dopamine antagonists against insomnia and nocturnal delirium.
    Kambayashi R; Hagiwara-Nagasawa M; Goto A; Chiba K; Izumi-Nakaseko H; Naito AT; Matsumoto A; Sugiyama A
    Heart Vessels; 2020 Apr; 35(4):593-602. PubMed ID: 31628538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiohemodynamic and Arrhythmogenic Effects of the Anti-Atrial Fibrillatory Compound Vanoxerine in Halothane-Anesthetized Dogs.
    Hagiwara-Nagasawa M; Kambayashi R; Goto A; Nunoi Y; Izumi-Nakaseko H; Takei Y; Matsumoto A; Sugiyama A
    Cardiovasc Toxicol; 2021 Mar; 21(3):206-215. PubMed ID: 33074476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of Safety Margin of Lithium Carbonate Against Cardiovascular Adverse Events Assessed in the Halothane-Anesthetized Dogs.
    Goto A; Nakamura Y; Lubna NJ; Chiba K; Hagiwara-Nagasawa M; Izumi-Nakaseko H; Ando K; Naito AT; Sugiyama A
    Cardiovasc Toxicol; 2018 Dec; 18(6):530-536. PubMed ID: 29845450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo Analysis of the Anti-atrial Fibrillatory, Proarrhythmic and Cardiodepressive Profiles of Dronedarone as a Guide for Safety Pharmacological Evaluation of Antiarrhythmic Drugs.
    Motokawa Y; Nakamura Y; Hagiwara-Nagasawa M; Goto A; Chiba K; Lubna NJ; Izumi-Nakaseko H; Ando K; Naito AT; Yamazaki H; Sugiyama A
    Cardiovasc Toxicol; 2018 Jun; 18(3):242-251. PubMed ID: 29139031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of electropharmacological and proarrhythmic effects of donepezil using the halothane-anesthetized intact dogs and the conscious chronic atrioventricular block ones.
    Hagiwara-Nagasawa M; Kambayashi R; Goto A; Nunoi Y; Izumi-Nakaseko H; Chiba K; Wada T; Takei Y; Matsumoto A; Sugiyama A
    Naunyn Schmiedebergs Arch Pharmacol; 2021 Apr; 394(4):581-589. PubMed ID: 33064166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How the Deuteration of Dronedarone Can Modify Its Cardiovascular Profile: In Vivo Characterization of Electropharmacological Effects of Poyendarone, a Deuterated Analogue of Dronedarone.
    Kambayashi R; Hagiwara-Nagasawa M; Kondo Y; Yeo ZJ; Goto A; Chiba K; Nunoi Y; Izumi-Nakaseko H; Leow JWH; Venkatesan G; Matsumoto A; Chan ECY; Sugiyama A
    Cardiovasc Toxicol; 2020 Aug; 20(4):339-350. PubMed ID: 31898152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electropharmacological characterization of microminipigs as a laboratory animal using anti-influenza virus drug oseltamivir.
    Lubna NJ; Nakamura Y; Hagiwara-Nagasawa M; Goto A; Chiba K; Kitta K; Izumi-Nakaseko H; Ando K; Naito AT; Akie Y; Sugiyama A
    J Toxicol Sci; 2018; 43(8):507-512. PubMed ID: 30078836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiohemodynamic and electrophysiological effects of a selective EP4 receptor agonist ONO--AE1--329 in the halothane-anesthetized dogs.
    Nomura H; Nakamura Y; Cao X; Honda A; Katagi J; Ohara H; Izumi-Nakaseko H; Satoh Y; Ando K; Sugiyama A
    Eur J Pharmacol; 2015 Aug; 761():217-25. PubMed ID: 26073024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reverse translational analysis of clinically reported, lamotrigine-induced cardiovascular adverse events using the halothane-anesthetized dogs.
    Goto A; Hagiwara-Nagasawa M; Kambayashi R; Nunoi Y; Izumi-Nakaseko H; Kawai S; Takei Y; Matsumoto A; Sugiyama A
    Heart Vessels; 2021 Mar; 36(3):424-429. PubMed ID: 33136260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the electropharmacological effects of verapamil and propranolol in the halothane-anesthetized in vivo canine model under monophasic action potential monitoring.
    Shiina H; Sugiyama A; Takahara A; Satoh Y; Hashimoto K
    Jpn Circ J; 2000 Oct; 64(10):777-82. PubMed ID: 11059619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of clinically-reported, memantine-induced cardiovascular adverse responses using the halothane-anesthetized dogs: Reverse translational study.
    Kambayashi R; Goto A; Hagiwara-Nagasawa M; Izumi-Nakaseko H; Shinozaki M; Kawai S; Matsumoto A; Takei Y; Sugiyama A
    J Pharmacol Sci; 2022 Apr; 148(4):343-350. PubMed ID: 35300808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of electropharmacological effects between terfenadine and its active derivative fexofenadine using a cross-over study in halothane-anesthetized dogs to analyze variability of pharmacodynamic and pharmacokinetic profiles of terfenadine and torsadogenic risk of fexofenadine.
    Ando K; Nakamura Y; Hagiwara-Nagasawa M; Harada H; Miyamoto H; Inamura N; Takagi K; Goto A; Chiba K; Lubna NJ; Izumi-Nakaseko H; Naito AT; Sugiyama A
    J Toxicol Sci; 2018; 43(3):183-192. PubMed ID: 29540652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dasatinib can Impair Left Ventricular Mechanical Function But May Lack Proarrhythmic Effect: A Proposal of Non-clinical Guidance for Predicting Clinical Cardiovascular Adverse Events of Tyrosine Kinase Inhibitors.
    Izumi-Nakaseko H; Fujiyoshi M; Hagiwara-Nagasawa M; Goto A; Chiba K; Kambayashi R; Naito AT; Ando K; Kanda Y; Ishii I; Sugiyama A
    Cardiovasc Toxicol; 2020 Feb; 20(1):58-70. PubMed ID: 31280457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bradycardia-dependent triggered activity: relevance to drug-induced multiform ventricular tachycardia.
    Brachmann J; Scherlag BJ; Rosenshtraukh LV; Lazzara R
    Circulation; 1983 Oct; 68(4):846-56. PubMed ID: 6616779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluvoxamine by itself has potential to directly induce long QT syndrome at supra-therapeutic concentrations.
    Yamazaki-Hashimoto Y; Nakamura Y; Ohara H; Cao X; Kitahara K; Izumi-Nakaseko H; Ando K; Yamazaki H; Ikeda T; Yamazaki J; Sugiyama A
    J Toxicol Sci; 2015 Feb; 40(1):33-42. PubMed ID: 25560394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of halothane and quinidine on intracardiac conduction and QTc interval in pentobarbital-anesthetized dogs.
    Gallagher JD
    Anesth Analg; 1992 Nov; 75(5):688-95. PubMed ID: 1416119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of electropharmacological effects of bepridil and sotalol in halothane-anesthetized dogs.
    Ishizaka T; Takahara A; Iwasaki H; Mitsumori Y; Kise H; Nakamura Y; Sugiyama A
    Circ J; 2008 Jun; 72(6):1003-11. PubMed ID: 18503230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.